Evidence map›Paper›PMID 33490186›Full record

ArticleAnnals of translational medicine2020

MicroRNA-30/Cx43 axis contributes to podocyte injury by regulating ER stress in diabetic nephropathy.

Min Li, Weijie Ni, Mengyu Zhang, Shusu Liu, Mengting Chen, Xiwei Hong, Yubo Ma, Xinyang Yu, Weilang Wang, Min Yang and 1 more

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Podocytes and microRNA-30/Cx43 axis in diabetic nephropathy.Annals of translational medicine · 2021
    Article
  7. MicroRNAs for podocyte injury in diabetic nephropathy.Annals of translational medicine · 2021
    Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Min LiDepartment of Nephrology, the Third Affiliated Hospital of Soochow University, Changzhou, China.
Weijie NiSoutheast University School of Medicine, Nanjing, China.
Mengyu ZhangDepartment of Nephrology, the Third Affiliated Hospital of Soochow University, Changzhou, China.
Shusu LiuDepartment of Nephrology, the Third Affiliated Hospital of Soochow University, Changzhou, China.
Mengting ChenSoutheast University School of Medicine, Nanjing, China.
Xiwei HongSoutheast University School of Medicine, Nanjing, China.
Yubo MaSoutheast University School of Medicine, Nanjing, China.
Xinyang YuSoutheast University School of Medicine, Nanjing, China.
Weilang WangSoutheast University School of Medicine, Nanjing, China.
Min YangDepartment of Nephrology, the Third Affiliated Hospital of Soochow University, Changzhou, China.
Fei HuaDepartment of Endocrinology, the Third Affiliated Hospital of Soochow University, Changzhou, China.
Southeast University · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe microRNA-30 family plays a critical role in the pathogenesis of podocyte injury. Cx43 plays an essential role in intercellular communication, which is essential for coordinated kidney function. This study was conducted to explore the function of microRNA-30s/Cx43 in podocyte injury in diabetic nephropathy (DN), both

methodsSD rats were given streptozotocin (STZ) injections to induce DN. Podocytes were incubated in the medium in the presence or absence of high glucose (HG). The effects of the microRNA-30/Cx43 axis on DN and its underlying mechanisms were investigated by TUNEL assay, PAS, immunohistochemical staining, immunofluorescence staining, Western blot, RT-qPCR, RNA interference, and luciferase reporter assay. Podocytes were transfected with microRNA-30 family mimics, microRNA-30 family inhibitors, Cx43 siRNA, and negative controls to detect the effect of the microRNA-30/Cx43 axis. MicroRNA-30 family mimic AAVs, and microRNA-30 family inhibitor AAVs applied to regulate microRNA-30 family expression in the kidneys of the STZ-induced DN model rats to reveal the underlying mechanisms of the microRNA-30/Cx43 axis in DN.

resultsMicroRNA-30 family member expression was downregulated in HG-treated podocytes and the glomeruli of STZ-induced DN rats. Luciferase reporter assays confirmed Cx43 is a directed target of microRNA-30s. The overexpression of microRNA-30 family members attenuated the HG-induced podocyte injury and protected against podocyte apoptosis and endoplasmic reticulum stress (ERS) both

conclusionsThe overexpression of microRNA-30 family members prevents HG-induced podocyte injury and attenuates ERS by modulating Cx43 expression. The microRNA-30/Cx43/ERS axis might be a potential therapeutic target to treat DN.

Indexed as

Cx43diabetic nephrologyendoplasmic reticulum stress (ERS)MicroRNA-30spodocyte

Identifiers

PMID33490186
PMCPMC7812202
OpenAlexW3114362323

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.